NP has no choice but to play by the book. After al

NP has no choice but to play by the book. After all FDA has the final say and they are like NBA ref, you dont want to get 2T from them. However , we , the individual investors , can build up the pressure by spreading the words and this is something that all of us are doing. As a result, there are more news about Leronlimab than ever. Keep the pressure on and sooner or later, FDA will have to answer the question "When will Leronlimab be approved".